[Response to the letter to the editor of "Commentary on the COVID-19 mRNA vaccine reactogenicity study"]

Joan Ingles Torruella1, Rosa Maria Gil Soto2, Esther Sabaté Aguila3

  • 1Vicepresident SCSL, ES. jinglestorruella@gmail.com.